Janux Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of JANX for the last quarter is 1.25 M USD, and it's 49.13% lower compared to the previous quarter. The net income of Q1 24 is -14.76 M USD.